Lancet Infectious Diseases

The Lancet is a weekly peer-reviewed general medical journal. It is one of the world's best known, oldest, and most respected general medical journals. The Lancet was founded in 1823 by Thomas Wakley, an English surgeon who named it after the surgical instrument called a lancet, as well as after the term "lancet arch", a window with a sharp pointed arch, to indicate the "light of wisdom" or "to let in light". It publishes original research articles, review articles ("seminars" and "reviews"), editorials, book reviews, correspondence, as well as news features and case reports. The Lancet has been owned by Elsevier since 1991. As of 1995, the editor-in-chief is Richard Horton. The journal has editorial offices in London, New York, and Beijing. In the 2010 Journal Citation Reports, The Lancet s impact factor was ranked second among general medical journals, at 33.63, after The New England Journal of Medicine (53.48). The Lancet also has several speciality journals all bearing the parent title: The Lancet Neurology (neurology), The Lancet Oncology (oncology), and The Lancet Infectious Diseases (infectious diseases), all of which publish original research and reviews. These three

Publisher
Elsevier
History
1823-present
Website
http://www.thelancet.com/journals/lancet/issue/current
Impact factor
33.633 (2010)

Some content from Wikipedia, licensed under CC BY-SA

Diseases, Conditions, Syndromes

Contact tracing can cut time to case isolation in SARS-CoV-2

(HealthDay)—Contact tracing can reduce the time to case isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), according to a study published online April 27 in The Lancet Infectious Diseases.

Diseases, Conditions, Syndromes

New evidence for optimizing malaria treatment in pregnant women

The research, published today in The Lancet Infectious Diseases is the fruit of joint project between investigators from around the world to conduct the largest individual patient data meta-analysis to date under the WWARN ...

Diseases, Conditions, Syndromes

Promising MERS coronavirus vaccine trial in humans

Researchers at the German Center for Infection Research (DZIF) have reported on a safety trial of a promising vaccine for MERS coronavirus. According to their study, published in The Lancet Infectious Diseases, vaccination ...

page 1 from 27